1150 related articles for article (PubMed ID: 26718510)
1. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
[TBL] [Abstract][Full Text] [Related]
2. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
[TBL] [Abstract][Full Text] [Related]
4. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
Makkar RR; Cheng W; Waksman R; Satler LF; Chakravarty T; Groh M; Abernethy W; Russo MJ; Heimansohn D; Hermiller J; Worthley S; Chehab B; Cunningham M; Matthews R; Ramana RK; Yong G; Ruiz CE; Chen C; Asch FM; Nakamura M; Jilaihawi H; Sharma R; Yoon SH; Pichard AD; Kapadia S; Reardon MJ; Bhatt DL; Fontana GP
Lancet; 2020 Sep; 396(10252):669-683. PubMed ID: 32593323
[TBL] [Abstract][Full Text] [Related]
5. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
[TBL] [Abstract][Full Text] [Related]
6. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
Herrmann HC; Thourani VH; Kodali SK; Makkar RR; Szeto WY; Anwaruddin S; Desai N; Lim S; Malaisrie SC; Kereiakes DJ; Ramee S; Greason KL; Kapadia S; Babaliaros V; Hahn RT; Pibarot P; Weissman NJ; Leipsic J; Whisenant BK; Webb JG; Mack MJ; Leon MB;
Circulation; 2016 Jul; 134(2):130-40. PubMed ID: 27400898
[TBL] [Abstract][Full Text] [Related]
7. A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study.
Mas-Peiro S; Seppelt PC; Weiler H; Mohr GL; Papadopoulos N; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M
J Invasive Cardiol; 2019 Jul; 31(7):E199-E204. PubMed ID: 31257214
[TBL] [Abstract][Full Text] [Related]
8. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis.
Pendyala LK; Minha S; Barbash IM; Torguson R; Magalhaes MA; Okubagzi P; Loh JP; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jan; 113(2):342-7. PubMed ID: 24220281
[TBL] [Abstract][Full Text] [Related]
9. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry.
Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580
[TBL] [Abstract][Full Text] [Related]
10. Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve.
Pibarot P; Hahn RT; Weissman NJ; Arsenault M; Beaudoin J; Bernier M; Dahou A; Khalique OK; Asch FM; Toubal O; Leipsic J; Blanke P; Zhang F; Parvataneni R; Alu M; Herrmann H; Makkar R; Mack M; Smalling R; Leon M; Thourani VH; Kodali S
JAMA Cardiol; 2017 Nov; 2(11):1208-1216. PubMed ID: 28973091
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
[TBL] [Abstract][Full Text] [Related]
12. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
[TBL] [Abstract][Full Text] [Related]
13. Self-expanding Portico Valve Versus Balloon-expandable SAPIEN XT Valve in Patients With Small Aortic Annuli: Comparison of Hemodynamic Performance.
Del Trigo M; Dahou A; Webb JG; Dvir D; Puri R; Abdul-Jawad Altisent O; Campelo-Parada F; Thompson C; Leipsic J; Stub D; DeLarochellière R; Paradis JM; Dumont E; Doyle D; Mohammadi S; Pasian S; Côté M; Pibarot P; Rodés-Cabau J
Rev Esp Cardiol (Engl Ed); 2016 May; 69(5):501-8. PubMed ID: 26739827
[TBL] [Abstract][Full Text] [Related]
14. Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts.
Szerlip M; Gualano S; Holper E; Squiers JJ; White JM; Doshi D; Williams MR; Hahn RT; Webb JG; Svensson LG; Kirtane AJ; Cohen DJ; Douglas PS; Alu MC; Crowley A; Tuzcu EM; Makkar RR; Herrmann HC; Babaliaros V; Thourani VH; Leon MB; Kodali SK; Mack MJ
JACC Cardiovasc Interv; 2018 Jan; 11(1):13-20. PubMed ID: 29301644
[TBL] [Abstract][Full Text] [Related]
15. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
[TBL] [Abstract][Full Text] [Related]
16. 1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial.
Abdel-Wahab M; Neumann FJ; Mehilli J; Frerker C; Richardt D; Landt M; Jose J; Toelg R; Kuck KH; Massberg S; Robinson DR; El-Mawardy M; Richardt G;
J Am Coll Cardiol; 2015 Aug; 66(7):791-800. PubMed ID: 26271061
[TBL] [Abstract][Full Text] [Related]
17. Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves.
Binder RK; Stortecky S; Heg D; Tueller D; Jeger R; Toggweiler S; Pedrazzini G; Amann FW; Ferrari E; Noble S; Nietlispach F; Maisano F; Räber L; Roffi M; Grünenfelder J; Jüni P; Huber C; Windecker S; Wenaweser P
Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26453687
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
[TBL] [Abstract][Full Text] [Related]
19. Transaortic transcatheter aortic valve implantation: experience from the Kiel study.
Petzina R; Lutter G; Wolf C; Kühl C; Freitag-Wolf S; Panholzer B; Bramlage P; Frey N; Cremer J; Frank D
Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):55-62. PubMed ID: 27600910
[TBL] [Abstract][Full Text] [Related]
20. Computed Tomography-Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve.
Blanke P; Pibarot P; Hahn R; Weissman N; Kodali S; Thourani V; Parvataneni R; Dvir D; Naoum C; Nørgaard BL; Douglas P; Jaber W; Khalique OK; Jilaihawi H; Mack M; Smith C; Leon M; Webb J; Leipsic J
JACC Cardiovasc Interv; 2017 Apr; 10(8):810-820. PubMed ID: 28427598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
